Blood test to guide extra treatment after radiation for early lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial uses a blood test to look for cancer DNA after radiation therapy. The results help doctors decide if you need extra treatment, and the goal is to find the best way to prevent the cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have non-small cell lung cancer that is early stage.
- You must be between 18 and 80 years old.
- You must have had stereotactic body radiation therapy (SBRT) for your cancer.
- Your blood counts and liver/kidney function must be within acceptable ranges.
- You cannot have small cell lung cancer or any condition that prevents you from taking oral or IV medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single very high dose of precisely targeted radiation to treat early-stage lung cancer. It aims to destroy the tumor with one treatment session, which may be more convenient and effective than standard radiation.
This study looks at changes in small molecules, genetic material, and other markers in the blood before and after lung cancer surgery. The goal is to develop a simple blood test to monitor patients over time and see if the cancer comes back.
This study tests whether a simple blood test (liquid biopsy) can help doctors monitor for cancer returning after surgery for early-stage lung cancer. It is for people with non-small cell lung cancer that can be removed with surgery.
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
This trial tests whether a simple blood test (ctDNA) can help doctors decide if you need radiation therapy after lung cancer surgery. The goal is to tailor your treatment to your individual risk, possibly avoiding extra radiation if you don't need it.
This trial uses a blood test to look for tiny bits of cancer DNA after treatment. It may help find early signs that lung cancer has come back, so doctors can act sooner.
Hear when a new Stereotactic Body Radiation Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.